Circulating tumor DNA(ctDNA) level measurement

DIAGNOSTIC_TEST2 trials

Sponsors

Medical College of Wisconsin

Conditions

Adenocarcinoma EsophagusRectal Cancer

Unknown Phase

Response Assessment by Circulating Tumor DNA in Patients With Locally Advanced Rectal Cancer

WithdrawnNCT04670588

Medical College of WisconsinRectal Cancer

Start: 2021-03-31End: 2022-06-01Updated: 2022-07-18

Circulating Tumor DNA (ctDNA) in Locally Advanced Esophageal and Gastroesophageal (GE) Junction Adenocarcinoma

WithdrawnNCT05067842

Medical College of WisconsinAdenocarcinoma Esophagus

Start: 2022-05-13End: 2025-05-30Updated: 2025-06-08

Related Papers

A prospective observational study to determine the feasibility of tumor response assessment by circulating tumor DNA (ctDNA) in patients with locally advanced rectal cancer (LARC) undergoing total neoadjuvant therapy (TNT).

Journal of Clinical Oncology2022-01-19